Skip to main content
An official website of the United States government
Español
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

Nivestym

(NY-ves-tim)
A drug that contains the active ingredient filgrastim and is used to treat neutropenia (a lower-than-normal number of white blood cells), prevent infection, and prepare the blood for the collection of certain types of blood cells. Nivestym is used in patients who have certain cancers and neutropenia caused by some types of chemotherapy and in patients who have severe chronic neutropenia that is not caused by cancer treatment. It is also used before an autologous stem cell transplant. Nivestym helps the bone marrow make more white blood cells. It is a type of colony-stimulating factor.
Search NCI's Dictionary of Cancer Terms